223 related articles for article (PubMed ID: 27447482)
1. Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer.
Hu CY; Zhang YH; Wang T; Chen L; Gong ZH; Wan YS; Li QJ; Li YS; Zhu B
Clin Exp Immunol; 2016 Oct; 186(1):106-14. PubMed ID: 27447482
[TBL] [Abstract][Full Text] [Related]
2. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
[TBL] [Abstract][Full Text] [Related]
3. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.
Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiong XZ; Zhang JC; Shi HZ
Am J Respir Crit Care Med; 2012 Dec; 186(11):1168-79. PubMed ID: 23065014
[TBL] [Abstract][Full Text] [Related]
5. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
Front Immunol; 2021; 12():760683. PubMed ID: 34966384
[TBL] [Abstract][Full Text] [Related]
6. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
Baxevanis CN; Dedoussis GV; Gritzapis AD; Stathopoulos GP; Papamichail M
Br J Cancer; 1994 Oct; 70(4):625-30. PubMed ID: 7917907
[TBL] [Abstract][Full Text] [Related]
8. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
Liu YL; Wu YB; Zhai K; Wang XJ; Shi HZ
Sci Rep; 2016 Jan; 6():19424. PubMed ID: 26783266
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional characterizations of CD8
Zhang Y; Li W; Zhai J; Jin Y; Zhang L; Chen C
Exp Cell Res; 2022 Aug; 417(1):113212. PubMed ID: 35588796
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease.
Ekeke CN; Russell KL; Murthy P; Guo ZS; Soloff AC; Weber D; Pan W; Lotze MT; Dhupar R
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):e313-e328. PubMed ID: 33485667
[TBL] [Abstract][Full Text] [Related]
11. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
[TBL] [Abstract][Full Text] [Related]
12. The Detection of Immunity against WT1 and SMAD4
Koya T; Niida Y; Togi M; Yoshida K; Sakamoto T; Ura H; Togi S; Kato T; Yamada S; Sugiyama H; Koido S; Shimodaira S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293034
[TBL] [Abstract][Full Text] [Related]
13. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
[TBL] [Abstract][Full Text] [Related]
14. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.
Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H
Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421
[TBL] [Abstract][Full Text] [Related]
16. Cell origins and significance of IL-17 in malignant pleural effusion.
Gong Y; Chen SX; Gao BA; Yao RC; Guan L
Clin Transl Oncol; 2014 Sep; 16(9):807-13. PubMed ID: 24399072
[TBL] [Abstract][Full Text] [Related]
17. Activation of Valpha24NKT cells in malignant pleural effusion in patients with lung cancer.
Shimizu T; Takahashi N; Terakado M; Tsujino I; Hashimoto S
Oncol Rep; 2009 Sep; 22(3):581-6. PubMed ID: 19639207
[TBL] [Abstract][Full Text] [Related]
18. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
20. Abnormally high expression of BAFF on T lymphocytes from lung cancer-associated pleural effusions and its potent anti-tumor effect.
Xu H; He X; Zhu Y; Yan T; Ma H; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):964-73. PubMed ID: 18064389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]